Romiplostim

Details

Files

Generic Name:

Romiplostim

Project Status:

Complete

Therapeutic Area:

Chronic immune (idiopathic) thrombocytopenic purpura (ITP)

Manufacturer:

Amgen Canada Inc.

Brand Name:

Nplate

Project Line:

Reimbursement Review

Project Number:

SR0179-000

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

Chronic immune (idiopathic) thrombocytopenic purpura (ITP)

Recommendation Type:

Do not list

Final Recommendation:

May 27, 2010

Last Updated : September 29, 2009